MOLECULAR ASPECTS OF THE IMPACT OF THE SPEROTON COMPLEX ON THE MALE FERTILITY IN IDIOPATHIC INFERTILITY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim To characterize the effect of the Speroton complex on the free radical homeostasis in the ejaculate of males of infertile couples and the likelihood of pregnancy in partners. Materials and methods The study group comprised 30 men aged between 26 and 43 years (mean 33 ± 4.8 years) with idiopathic infertility. All patients received Speroton one sachet once daily during meals for 3 months. The comparison group consisted of 29 men of fertile age having 1 to 3 healthy children. In infertile men, standard semen parameters including the ejaculate volume, sperm concentration, total count and proportion of abnormal forms were within the normal range. Markers of oxidative damage to ejaculate macromolecules were determined using standard diagnostic testing systems. Results The patients with idiopathic infertility were found to have statistically significant changes in the degree of chemical modification of ejaculate biopolymers. The level of lipid hydroperoxides in infertile men was significantly higher than in fertile participants. Taking Speroton resulted in the decrease of lipid hydroperoxides to the level that did not differ from that in the control group. Using Speroton was also accompanied by a decrease in the level of the oxidative damage DNA biomarker 8-oxodGu and a tendency toward normalization of the carbonyl modification of the ejaculate proteins. Five married couples in the treatment group reported achieving pregnancy. Conclusion Taking Speroton was associated with the normalization of the balance of pro- and antioxidant processes in the ejaculate, as indicated by a decrease in the oxidative destruction of sperm biopolymers. The revealed molecular mechanism of the drug action is the basis for restoring the fertilizing ability and increasing the likelihood of pregnancy. The treatment effectiveness was 16.7%. Speroton is a promising drug that improves the functional sperm characteristics and contributes to achieving pregnancy in couples with a male infertility factor.

Full Text

Restricted Access

About the authors

Sh. N Galimov

Bashkir State Medical University of Minzdrav of Russia

Email: sngalrm@mail.ru
Dr.Med.Sci., Professor, Head of the Department of Biological Chemistry Ufa, Russia

R. M Akhmetov

Republican Perinatal Center

Email: ufa.rpc@doctorrb.ru
Urologist Ufa, Russia

E. F Galimova

Bashkir State Medical University of Minzdrav of Russia

Email: efgalimova@mail.ru
Dr.Med.Sci., Leading Researcher at the Central Research Laboratory Ufa, Russia

F. M Bairamgulov

Republican Perinatal Center

Email: chiefrpc@yandex.ru
Chief Physician Ufa, Russia

L. R Bikkulova

Republican Perinatal Center

Biologist Ufa, Russia

References

  1. Kashanian J., Brannigan R. Male JAMA patient page. Male infertility. JAMA. 2015;313(17):1770.
  2. Ko E., Siddiqi K., Brannigan R., Sabanegh E. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J. Urol. 2012;187:973-978.
  3. Agarwal A., Sharma R., Sharma R. Characterizing semen parameters and their association with reactive oxygen species in infertile men. Reprod. Biol. Endocrinol. 2014;12:33.
  4. Bozhedomov V.A. Muzhskoj faktor bezdetnogo braka - puti reshenija problemy. Urologija. 2016; 1:28-34. Russian (Божедомов В.А. Мужской фактор бездетного брака - пути решения проблемы. Урология. 2016;1:28-34).
  5. Aitken R.J. Oxidative stress and the etiology of male infertility. J. Assist. Reprod. Genet. 2016;33(12):1691-1692.
  6. Gharagozloo P., Gutierrez-Adan A., Champroux A., Noblanc A., Kocer A., Drevet J.R., Moazamian A. Aitken R.J. A novel antioxidant formulation designed to treat male infertility associated with oxidative stress: Promising predinical evidence from animal models. Human Reproduction. 2016;31(2):252-262. doi: 10.1093/humrep/ dev302.
  7. Lipovac M., Bodner F., Imhof M., Chedraui P. Comparison of the effect of a combination of eight micronutrients versus a standard mono preparation on sperm parameters. Reprod. Biol. Endocrinol. 2016;14(1):84.
  8. Pavlov V.N., Galimova E.F., Teregulov B.F., Kajbyshev V.T., Galimov Sh.N. Molekuljarnye i metabolicheskie aspekty muzhskogo besplodija. Vestnik urologii. 2016;2:40-59. Russian (Павлов В.Н., Галимова Э.Ф., Терегулов Б.Ф., Кайбышев В.Т., Галимов Ш.Н. Молекулярные и метаболические аспекты мужского бесплодия. Вестник урологии. 2016;2:40-59).
  9. Showell M.G., Mackenzie-Proctor R., Brown J., Yazdani A., Stankiewicz M.T., Hart R.J. Antioxidants for male subfertility. Cochrane Database Syst. Rev. 2014;12:CD007411. doi: 10.1002/14651858. CD0077411. pub3.
  10. Brody S. Male factor infertility and oxidative stress: role of diet, lifestyle and nutritional supplements. Androl. Genit. Surg. 2014;15(3):33-41.
  11. Suhih G.T., Popova A.Y., Ovchinnikov R.I., Ushakova I.V. Vliyanie kompleksa speroton na funkcional’nye harakteristiki spermatozoidov u muzhchin s idiopaticheskoj patozoospermiej. Problemy reprodukcii. 2016;22(4);106-110

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies